FDA Using Ion Mobility Spectrometers In 4 IMFs, Plans Use In 4 More
Executive Summary
Across all 9 IMF facilities in FY 2019, FDA screened around 25,200 parcels containing more than 41,000 products, detained more than 38,000 including 1,801 identified as supplements and expects to destroy more than 17,000.
You may also be interested in...
'Herbal Supplement' Marketer Faces Prison For Distributing Unapproved Drugs
Following FDA investigation, Kansas businessman Rick Shepard was indicted on charges of conspiracy and introducing misbranded drugs into interstate commerce. In addition to purchasing the drugs from a supplier in China, indictment alleged he had the drugs in packages were labeled “healthy food samples” delivered to private shipping and mailing stores throughout the country.
US House Committee Requests Proof Of FDA Progress Seizing Opioids In International Mail
Energy & Commerce's Republican and Democrat leadership ask FDA Commissioner Scott Gottlieb about work by the agency's Office of Criminal Investigations focused on opioid drugs, the office's staffing and its priorities. They note FDA's FY2018 appropriation included $94m for its work in international mail facilities.
Ion Spectrometer Improves FDA's Import Screening: Health And Wellness Industry News
FDA implementing ion mobility spectrometer devices for faster import screening; Kratom products recalled in Utah in salmonella investigation; ABC names Low Dog first Kronenberg Award winner; and AHPA revises liability insurance primer.